PL366800A1 - Tabletka zawierająca cetyryzynę i pseudoefedrynę - Google Patents
Tabletka zawierająca cetyryzynę i pseudoefedrynęInfo
- Publication number
- PL366800A1 PL366800A1 PL02366800A PL36680002A PL366800A1 PL 366800 A1 PL366800 A1 PL 366800A1 PL 02366800 A PL02366800 A PL 02366800A PL 36680002 A PL36680002 A PL 36680002A PL 366800 A1 PL366800 A1 PL 366800A1
- Authority
- PL
- Poland
- Prior art keywords
- tablet
- cetirizine
- pseudoephedrine
- combinations
- treatment
- Prior art date
Links
- ZKLPARSLTMPFCP-UHFFFAOYSA-N Cetirizine Chemical compound C1CN(CCOCC(=O)O)CCN1C(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 ZKLPARSLTMPFCP-UHFFFAOYSA-N 0.000 title 1
- 229960001803 cetirizine Drugs 0.000 title 1
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 title 1
- KWGRBVOPPLSCSI-WCBMZHEXSA-N pseudoephedrine Chemical compound CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WCBMZHEXSA-N 0.000 title 1
- 229960003908 pseudoephedrine Drugs 0.000 title 1
- 230000000172 allergic effect Effects 0.000 abstract 1
- 208000010668 atopic eczema Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Ophthalmology & Optometry (AREA)
- Immunology (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30125001P | 2001-06-28 | 2001-06-28 | |
| EP01115807 | 2001-06-28 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL366800A1 true PL366800A1 (pl) | 2005-02-07 |
| PL206069B1 PL206069B1 (pl) | 2010-06-30 |
Family
ID=56290291
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL366800A PL206069B1 (pl) | 2001-06-28 | 2002-06-10 | Tabletka dwuwarstwowa zawierająca cetyryzynę i pseudoefedrynę |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP1404304B1 (pl) |
| JP (1) | JP4041460B2 (pl) |
| KR (1) | KR100926410B1 (pl) |
| CN (1) | CN100490809C (pl) |
| AT (1) | ATE432068T1 (pl) |
| AU (1) | AU2002345024B2 (pl) |
| BR (1) | BR0210650A (pl) |
| CA (1) | CA2451519C (pl) |
| CZ (1) | CZ20033454A3 (pl) |
| DK (1) | DK1404304T3 (pl) |
| EE (1) | EE05357B1 (pl) |
| ES (1) | ES2324769T3 (pl) |
| HU (1) | HU229803B1 (pl) |
| MX (1) | MXPA03010430A (pl) |
| NZ (1) | NZ530289A (pl) |
| PL (1) | PL206069B1 (pl) |
| PT (1) | PT1404304E (pl) |
| RO (1) | RO122476B1 (pl) |
| RU (1) | RU2286784C2 (pl) |
| SI (1) | SI1404304T1 (pl) |
| SK (1) | SK287645B6 (pl) |
| WO (1) | WO2003002098A1 (pl) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7014867B2 (en) * | 2001-06-28 | 2006-03-21 | Ucb Farchim Sa | Tablet comprising cetirizine and pseudoephedrine |
| KR100698400B1 (ko) | 2004-04-14 | 2007-03-23 | 이은주 | 탈모증 및 전립선비대증 치료를 위한 약제학적 조성물 |
| US20100172984A1 (en) * | 2006-06-06 | 2010-07-08 | Bijay Kumar Padhi | tablet dosage form comprising cetirizine and pseudoephedrine |
| EP2626067A1 (en) * | 2006-12-26 | 2013-08-14 | Pharmacyclics, Inc. | Method of using histone deacetylase inhibitors and monitoring biomarkers in combination therapy |
| US8439033B2 (en) | 2007-10-09 | 2013-05-14 | Microdose Therapeutx, Inc. | Inhalation device |
| JP6017961B2 (ja) | 2010-01-05 | 2016-11-02 | マイクロドース セラピューテクス，インコーポレイテッド | 吸入デバイスおよび方法 |
| KR101193495B1 (ko) | 2010-02-01 | 2012-10-23 | 한미사이언스 주식회사 | 슈도에페드린 및 레보세티리진을 포함하는 경구용 복합 조성물 |
| CA2802853C (en) | 2010-06-16 | 2016-07-26 | Bruce Chandler May | Use of levocetirizine and montelukast in the treatment of influenza, common cold and inflammation |
| CN102302497A (zh) * | 2011-05-18 | 2012-01-04 | 天圣制药集团股份有限公司 | 一种治疗过敏性鼻炎的制剂及其制备方法 |
| KR20130009553A (ko) | 2011-07-15 | 2013-01-23 | 한미약품 주식회사 | 몬테루카스트 또는 이의 약학적으로 허용가능한 염 및 레보세티리진 또는 이의 약학적으로 허용가능한 염을 함유하는 캡슐 제제 |
| EP2755648B1 (en) | 2011-09-13 | 2017-03-08 | Pharmacyclics LLC | Formulations of histone deacetylase inhibitor in combination with bendamustine and uses thereof |
| KR101372324B1 (ko) * | 2012-02-09 | 2014-03-13 | 동국대학교 경주캠퍼스 산학협력단 | 알러지성 비염 치료를 위한 한방 치료제 및 슈도에페드린을 함유한 복합서방형의 약제학적 조성물 |
| WO2014164299A1 (en) | 2013-03-13 | 2014-10-09 | Inflammatory Response Research, Inc. | Use of levocetirizine and montelukast in the treatment of autoimmune disorders |
| EP3308835B1 (en) | 2013-03-13 | 2020-01-01 | Inflammatory Response Research, Inc. | Use of levocetirizine and montelukast in the treatment of traumatic injury |
| CN105263579B (zh) | 2013-03-13 | 2020-01-10 | 炎症反应研究公司 | 左西替利嗪和孟鲁司特在治疗血管炎中的用途 |
| JP2017526728A (ja) | 2014-09-15 | 2017-09-14 | インフラマトリー・レスポンス・リサーチ・インコーポレイテッド | 炎症介在性状態の治療におけるレボセチリジン及びモンテルカスト |
| WO2016140630A1 (en) | 2015-03-05 | 2016-09-09 | PHARMACTIVE ILAÇ SANAYI VE TlCARET A. Ş. | An effervescent composition comprising levocetirizine and pseudoephedrine |
| KR20220137065A (ko) * | 2020-02-03 | 2022-10-11 | 존슨 앤드 존슨 컨수머 인코포레이티드 | 세티리진을 포함하는 단일층 츄어블 정제 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6469009B1 (en) * | 1996-04-08 | 2002-10-22 | Ucb, S.A. | Pharmaceutical compositions for the treatment of rhinitis |
| EP0811374A1 (en) * | 1996-05-29 | 1997-12-10 | Pfizer Inc. | Combination dosage form comprising cetirizine and pseudoephedrine |
| BE1011045A3 (fr) * | 1997-03-14 | 1999-04-06 | Ucb Sa | Compositions pharmaceutiques pour la liberation controlee de substances actives. |
| US6267986B1 (en) * | 1999-09-24 | 2001-07-31 | Ranbaxy Laboratories Limited | Process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long acting antihistamine |
-
2002
- 2002-06-10 HU HU0400386A patent/HU229803B1/hu unknown
- 2002-06-10 JP JP2003508337A patent/JP4041460B2/ja not_active Expired - Fee Related
- 2002-06-10 CA CA002451519A patent/CA2451519C/en not_active Expired - Lifetime
- 2002-06-10 BR BR0210650-7A patent/BR0210650A/pt not_active Application Discontinuation
- 2002-06-10 EE EEP200400005A patent/EE05357B1/xx unknown
- 2002-06-10 PT PT02743173T patent/PT1404304E/pt unknown
- 2002-06-10 CN CNB02812975XA patent/CN100490809C/zh not_active Expired - Lifetime
- 2002-06-10 KR KR1020037017054A patent/KR100926410B1/ko not_active Expired - Lifetime
- 2002-06-10 CZ CZ20033454A patent/CZ20033454A3/cs unknown
- 2002-06-10 DK DK02743173T patent/DK1404304T3/da active
- 2002-06-10 MX MXPA03010430A patent/MXPA03010430A/es active IP Right Grant
- 2002-06-10 AU AU2002345024A patent/AU2002345024B2/en not_active Ceased
- 2002-06-10 RU RU2004101231/15A patent/RU2286784C2/ru active
- 2002-06-10 AT AT02743173T patent/ATE432068T1/de active
- 2002-06-10 WO PCT/EP2002/006342 patent/WO2003002098A1/en not_active Ceased
- 2002-06-10 RO ROA200301062A patent/RO122476B1/ro unknown
- 2002-06-10 SK SK1550-2003A patent/SK287645B6/sk not_active IP Right Cessation
- 2002-06-10 PL PL366800A patent/PL206069B1/pl unknown
- 2002-06-10 NZ NZ530289A patent/NZ530289A/en unknown
- 2002-06-10 ES ES02743173T patent/ES2324769T3/es not_active Expired - Lifetime
- 2002-06-10 SI SI200230844T patent/SI1404304T1/sl unknown
- 2002-06-10 EP EP02743173A patent/EP1404304B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CN1520285A (zh) | 2004-08-11 |
| HU229803B1 (en) | 2014-07-28 |
| PL206069B1 (pl) | 2010-06-30 |
| NZ530289A (en) | 2004-11-26 |
| ES2324769T3 (es) | 2009-08-14 |
| JP4041460B2 (ja) | 2008-01-30 |
| CZ20033454A3 (cs) | 2004-08-18 |
| EP1404304B1 (en) | 2009-05-27 |
| RU2286784C2 (ru) | 2006-11-10 |
| DK1404304T3 (da) | 2009-07-13 |
| KR100926410B1 (ko) | 2009-11-12 |
| ATE432068T1 (de) | 2009-06-15 |
| JP2004536829A (ja) | 2004-12-09 |
| WO2003002098A1 (en) | 2003-01-09 |
| KR20040007756A (ko) | 2004-01-24 |
| RO122476B1 (ro) | 2009-07-30 |
| CN100490809C (zh) | 2009-05-27 |
| PT1404304E (pt) | 2009-06-26 |
| HUP0400386A2 (hu) | 2004-08-30 |
| SK287645B6 (sk) | 2011-05-06 |
| CA2451519C (en) | 2007-11-06 |
| RU2004101231A (ru) | 2005-04-20 |
| BR0210650A (pt) | 2004-10-05 |
| AU2002345024B2 (en) | 2006-09-07 |
| HUP0400386A3 (en) | 2006-02-28 |
| CA2451519A1 (en) | 2003-01-09 |
| SI1404304T1 (sl) | 2009-10-31 |
| EP1404304A1 (en) | 2004-04-07 |
| EE05357B1 (et) | 2010-12-15 |
| EE200400005A (et) | 2004-02-16 |
| SK15502003A3 (sk) | 2004-05-04 |
| MXPA03010430A (es) | 2004-12-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL366800A1 (pl) | Tabletka zawierająca cetyryzynę i pseudoefedrynę | |
| HUP0302845A3 (en) | 4-fluoro-n-indan-2-yl benzamide and its use as pharmaceutical | |
| IL166405A0 (en) | 3-z-Ä1-4-(n-((4-methyl-piperazin-1-yl)methylcarbonyl)-n-methyl-aminoanilo)-1-phenyl-methyleneÜ-6-methyxycarbonyl-2-indoline-monoethanesulphonate and the use thereof as a pharmaceutical composition | |
| ATE318590T1 (de) | Arzneimittelkombinationen (z.b. chlorpromazin und pentamidin) zur therapie von neoplastischen erkrankungen | |
| PT1605956E (pt) | Administração de capsaicinóides para o tratamento da osteoartrite | |
| DE60225385D1 (de) | Autentisches Document und dessen Herstellungsverfahren | |
| WO2004006858A3 (en) | Compounds, compositions, and methods employing same | |
| ATE396202T1 (de) | Lang wirkendes glucagon-ähnliches peptid-2 für die behandlung von gastrointestinalen krankheiten und störungen | |
| AU2002334870B8 (en) | Combinations for the treatment of immunoinflammatory disorders | |
| PT1392292E (pt) | Piranoindazoles e sua utilizacao para o tratamento de glaucoma | |
| CY1109238T1 (el) | Δισκιο περιεχον σετιριζινη και ψευδοεφεδρινη | |
| AU2001266152A1 (en) | Novel substituted nitrocatechols, their use in the treatment of some central andperipheral nervous system disorders and pharmaceutical compositions containing them | |
| SG116507A1 (en) | Pharmaceutical dosage form and method of making. | |
| MXPA05012358A (es) | Combinacion farmaceutica que comprende modafinilo y otra droga. | |
| NO20033123D0 (no) | Terapeutisk hinnedannende sammensetning og behandlingsplan derav | |
| MXPA03007653A (es) | Uso de lp82 para tratar trastornos hematopoyeticos. | |
| AU2002224896A1 (en) | Parenteral dosage forms comprising a suspension of tramadol salt and diclofenac salt | |
| MXPA05005326A (es) | Tableta que comprende efletirizina y pseudoefedrina. | |
| IL158186A0 (en) | Pharmaceutically active compounds and methods of use | |
| AU2002354698A1 (en) | Use of xaa-pro peptidases for the treatment of substance p-related disorders | |
| AU2003255429A1 (en) | Use of treosulfan and derivatives thereof for treating multiple sclerosis | |
| HUP0102116A2 (hu) | Paroxetin-aszkorbát, eljárás az előállítására és gyógyászati alkalmazása | |
| SE0300830D0 (sv) | New formulations and use thereof | |
| WO2004024132A3 (de) | Modulatoren der no-signalkaskade zur regulation der humanen endostatinexpression | |
| AU8679801A (en) | Methods and pharmaceutical compositions employing desmethylselegiline to treat neoplastic diseases or conditions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RECP | Rectifications of patent specification |